Emendo Biotherapeutics
Dr. Ei Yamada, Ph.D. has been the President and Chief Executive Officer of AnGes Inc. and AnGes USA Inc. since 2002. Dr. Ei Yamada served with companies including Mitsubishi Chemical Corp., Sosei K.K, and Takara Shuzo Co. He serves as a Director of Dragon Genomics Inc. and Immuno Frontier, Inc. Dr. Yamada completed his studies in Medicine from Tohoku University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Emendo Biotherapeutics
1 followers
Emendo biotherapeutics develops next-generation gene-editing tools for genetic disorders, addressing the current technological gaps for realizing the promise of gene therapy.